<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39425074</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>The acceptance of COVID-19 vaccines in Rwanda: a cross-sectional study.</ArticleTitle><Pagination><StartPage>2875</StartPage><MedlinePgn>2875</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2875</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-20417-9</ELocationID><Abstract><AbstractText>The first reported case of Coronavirus Disease 2019 (COVID-19) in Rwanda occurred on March 14 2020. By the end of July 2024, a total of 133,518 individuals had tested positive for the infection, resulting in 1,468 deaths and 132,039 had fully recovered. The success of COVID-19 elimination in Rwanda hinges on the public's level of acceptance of the COVID-19 vaccination. Although COVID-19 is no longer a pandemic anymore, the World Health Organisation recommends countries vaccinate their populations to protect them from COVID-19 and its variants. Globally, COVID-19 has affected 704,753,890 people, caused 7,010,681 deaths and 675,619,811 have recovered. This study aimed to assess the acceptability of COVID-19 vaccines among adults aged 18 years and above in Rwanda. A cross-sectional study was conducted from January to March 2022 to determine the associations between COVID-19 vaccine acceptance (VA) with respondents' characteristics, using logistic regression analysis. This study enrolled 2,126 respondents with a mean age of 31 years, the majority of whom were females (82.2%), 51.4% had completed primary education, and 78.7% were married. Most respondents recognized the importance of COVID-19 vaccination for both personal health and community well-being. The study found a high rate of COVID-19 vaccine acceptance, with 91.6% of respondents expressing VA and an overall VA rate of 98.2%. Having a relationship with the child(ren) was the only characteristic associated with COVID-19 vaccine acceptance (p; 3.2 × 10<sup>- 3</sup>, OR; 2.9, 95% C.I; 1.4-5.9). In conclusion, the study found a high rate of COVID-19 vaccine acceptance among adults in Rwanda, with COVID-19 associated with having a relationship with the child(ren). The study recommends the need for mass educational campaigns and awareness-raising efforts to understand of COVID-19 vaccines.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mbonigaba</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre of Infectious Diseases, Division of Infectious Disease and Tropical Medicine, Universität Heidelberg, Heidelberg, Germany. edwardnkwaya@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Health Sciences, School of Public Health, University of Rwanda, Kigali, Rwanda. edwardnkwaya@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Fengyun</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Interdisciplinary Centre for Scientific Computing, Universität Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reñosa</LastName><ForeName>Mark Donald C</ForeName><Initials>MDC</Initials><AffiliationInfo><Affiliation>Heidelberg Institute of Global Health, Universität Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mwikarago</LastName><ForeName>Ivan Emil</ForeName><Initials>IE</Initials><AffiliationInfo><Affiliation>College of Medicine and Health Sciences, School of Public Health, University of Rwanda, Kigali, Rwanda.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rwanda Food and Drugs Authority, Division of Medicines, device assessment and registration, Kigali, Rwanda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Frederick Nchang</ForeName><Initials>FN</Initials><AffiliationInfo><Affiliation>Cameroon Baptist Convention Health Services - HIV free/Strengthening Public Health Laboratory Systems, Kumba, Cameroon.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Laboratory, Faculty of Health Sciences, University of Buea, Buea, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elad</LastName><ForeName>Peter Canisius Kuku</ForeName><Initials>PCK</Initials><AffiliationInfo><Affiliation>Cameroon Baptist Convention Health Services - HIV free/Strengthening Public Health Laboratory Systems, Kumba, Cameroon.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metzger</LastName><ForeName>Wolfram</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV, Eberhard-Karls Universität Tübingen, Tübingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muhindo</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Nursing Institute, College of Health Sciences, Makerere University, P.O BOX 7072, Kampala, Uganda.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of California, San Francisco, Berkeley, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qiushi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The Harold and Inge Marcus Department of Industrial and Manufacturing Engineering, The Pennsylvania State University, United States of America, University Park, Harrisburg, PA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denkinger</LastName><ForeName>Claudia M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Centre of Infectious Diseases, Division of Infectious Disease and Tropical Medicine, Universität Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMahon</LastName><ForeName>Shannon A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Centre of Infectious Diseases, Division of Infectious Disease and Tropical Medicine, Universität Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Simiao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre of Infectious Diseases, Division of Infectious Disease and Tropical Medicine, Universität Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012432" MajorTopicYN="N" Type="Geographic">Rwanda</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088823" MajorTopicYN="N">Vaccination Hesitancy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acceptability</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Rwanda</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword><Keyword MajorTopicYN="N">Vaccine acceptance</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>23</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39425074</ArticleId><ArticleId IdType="pmc">PMC11490121</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-20417-9</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-20417-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Okonji EF, Okonji OC, Mukumbang FC, Van Wyk B. Understanding varying COVID-19 mortality rates reported in Africa compared to Europe, Americas and Asia. Trop Med Int Health. 2021;26(7):716–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251241</ArticleId><ArticleId IdType="pubmed">33733568</ArticleId></ArticleIdList></Reference><Reference><Citation>Lone SA, Ahmad A. COVID-19 pandemic – an African perspective. Emerg Microbes Infect. 2020;9(1):1300–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473237</ArticleId><ArticleId IdType="pubmed">32458760</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of Coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–93.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO Coronavirus (COVID-19). Dashboard. 2023 [cited 2023 Oct 1]. https://covid19.who.int</Citation></Reference><Reference><Citation>Altman JD, Miner DS, Lee AA, Asay AE, Nielson BU, Rose AM, Hinton K, Poole BD. Factors affecting vaccine attitudes influenced by the COVID-19 pandemic. Vaccines. 2023;11(3):516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10057947</ArticleId><ArticleId IdType="pubmed">36992100</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamimes A, Aouissi HA, Ababsa M, Lounis M, Jayarajah U, Napoli C, Kasemy ZA. The effect of preventive measures and vaccination against SARS-CoV-2 on the infection risk, treatment, and hospitalization: a cross-sectional study of Algeria. Viruses. 2022;14(12):2771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10004600</ArticleId><ArticleId IdType="pubmed">36560775</ArticleId></ArticleIdList></Reference><Reference><Citation>Haug N, Geyrhofer L, Londei A, Dervic E, Desvars-Larrive A, Loreto V, Pinior B, Thurner S, Klimek P. Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Hum Behav. 2020;4(12):1303–12.</Citation><ArticleIdList><ArticleId IdType="pubmed">33199859</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Zhao S, Ou J, Zhang J, Lan W, Guan W, Wu X, Yan Y, Zhao W, Wu J, Chodosh J, Zhang Q. COVID-19: Coronavirus vaccine development updates. Front Immunol. 2020;11:602256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7785583</ArticleId><ArticleId IdType="pubmed">33424848</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson A, Robinson K, Vallée-Tourangeau G. The 5As: a practical taxonomy for the determinants of vaccine uptake. Vaccine. 2016;34(8):1018–24.</Citation><ArticleIdList><ArticleId IdType="pubmed">26672676</ArticleId></ArticleIdList></Reference><Reference><Citation>Badur S, Ota M, Öztürk S, Adegbola R, Dutta A. Vaccine confidence: the keys to restoring trust. Hum Vaccines Immunother. 2020;16(5):1007–17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227637</ArticleId><ArticleId IdType="pubmed">32298198</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">25896383</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. J Multidiscip Healthc. 2020;13:1657–63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7686470</ArticleId><ArticleId IdType="pubmed">33262600</ArticleId></ArticleIdList></Reference><Reference><Citation>Njoga EO, Awoyomi OJ, Onwumere-Idolor OS, Awoyomi PO, Ugochukwu ICI, Ozioko SN. Persisting vaccine hesitancy in Africa: the whys, global public health consequences and ways-out—COVID-19 vaccination acceptance rates as case-in-point. Vaccines. 2022;10(11):1934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9697713</ArticleId><ArticleId IdType="pubmed">36423029</ArticleId></ArticleIdList></Reference><Reference><Citation>Reñosa MDC, Wachinger J, Bärnighausen K, Endoma V, Landicho-Guevarra J, Landicho J, Bravo TA, Aligato M, McMahon SA. Misinformation, infighting, backlash, and an ‘endless’ recovery; policymakers recount challenges and mitigating measures after a vaccine scare in the Philippines. Glob Health Action. 2022;15(1):2077536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9359158</ArticleId><ArticleId IdType="pubmed">35930464</ArticleId></ArticleIdList></Reference><Reference><Citation>Coustasse A, Kimble C, Maxik K. COVID-19 and vaccine hesitancy: a challenge the United States must overcome. J Ambul Care Manage. 2021;44(1):71–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">33165121</ArticleId></ArticleIdList></Reference><Reference><Citation>Palache A, Rockman S, Taylor B, Akcay M, Billington JK, Barbosa P. IFPMA influenza vaccine supply (IFPMA IVS) task force. Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use. Vaccine. 2021;39(41):6081–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8433505</ArticleId><ArticleId IdType="pubmed">34521551</ArticleId></ArticleIdList></Reference><Reference><Citation>Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo O, Anigo D, Armand A, Asad S, Atyera M, Augsburg B, Awasthi M, Ayesiga GE, Bancalari A, Björkman Nyqvist M, Borisova E, Bosancianu CM, Cabra García MR, Cheema A, Collins E, Cuccaro F, Farooqi AZ, Fatima T, Fracchia M, Galindo Soria ML, Guariso A, Hasanain A, Jaramillo S, Kallon S, Kamwesigye A, Kharel A, Kreps S, Levine M, Littman R, Malik M, Manirabaruta G, Mfura JLH, Momoh F, Mucauque A, Mussa I, Nsabimana JA, Obara I, Otálora MJ, Ouédraogo BW, Pare TB, Platas MR, Polanco L, Qureshi JA, Raheem M, Ramakrishna V, Rendrá I, Shah T, Shaked SE, Shapiro JN, Svensson J, Tariq A, Tchibozo AM, Tiwana HA, Trivedi B, Vernot C, Vicente PC, Weissinger LB, Zafar B, Zhang B, Karlan D, Callen M, Teachout M, Humphreys M, Mobarak AM, Omer SB. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385–94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363502</ArticleId><ArticleId IdType="pubmed">34272499</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirsiy FS, Nkfusai CN, Ako-Arrey DE, Dongmo EK, Manjong FT, Cumber SN. Acceptability of COVID-19 vaccine in Africa. Int J MCH AIDS. 2021;10(1):134–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8039868</ArticleId><ArticleId IdType="pubmed">33868778</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim N, Jing L, Lee JA, Kharel R, Lubetkin D, Clancy CM, Uwamahoro D, Nahayo E, Biramahire J, Aluisio AR, Ndebwanimana V. Lessons learned from Rwanda: innovative strategies for prevention and containment of COVID-19. Ann Glob Health. 2021;87(1):23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7908927</ArticleId><ArticleId IdType="pubmed">33665145</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon S, Leigh J, Woskie L, Checchi F, Dzau V, Fallah M, Fitzgerald G, Garrett L, Gostin L, Heymann DL, Katz R, Kickbusch I, Morrison JS, Piot P, Sands P, Sridhar D, Jha AK. Post-ebola reforms: ample analysis, inadequate action. BMJ. 2017;356:j280.</Citation><ArticleIdList><ArticleId IdType="pubmed">28115316</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymann DL, Chen L, Takemi K, Fidler DP, Tappero JW, Thomas MJ, Kenyon TA, Frieden TR, Yach D, Nishtar S, Kalache A, Olliaro PL, Horby P, Torreele E, Gostin LO, Ndomondo-Sigonda M, Carpenter D, Rushton S, Lillywhite L, Devkota B, Koser K, Yates R, Dhillon RS, Rannan-Eliya RP. Global health security: the wider lessons from the west African Ebola virus disease epidemic. Lancet Lond Engl. 2015;385(9980):1884–901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856330</ArticleId><ArticleId IdType="pubmed">25987157</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis EF, Eugene D, Ingabire WC, Isano S, Blanc J. Rwanda’s resiliency during the Coronavirus disease pandemic. Front Psychiatry. 2022 [cited 2022 Apr 14];12. https://www.frontiersin.org/article/10.3389/fpsyt.2021.589526</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828737</ArticleId><ArticleId IdType="pubmed">35153844</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirsiy FS, Nkfusai CN, Ako-Arrey DE, Yeika EV, Manjong FT, Esther DK, Nzoyom RB, Atuhaire C, Wirsiy JCK, Cumber SN. COVID-19 pandemic: implementing control measures in Africa using the ‘SHEF2’ model. Pan Afr Med J. 2020;37(Suppl 1):3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7704345</ArticleId><ArticleId IdType="pubmed">33294104</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim SSA, Kelemu S, Baxter C. COVID-19 in Africa: catalyzing change for sustainable development. PLOS Med. 2021;18(11):e1003869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8668091</ArticleId><ArticleId IdType="pubmed">34843497</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Task Force Dashboard. COVID-19 task force dashboard. [cited 2023 May 15]. https://data.covid19taskforce.com/data/countries/Rwanda</Citation></Reference><Reference><Citation>Niyigena A, Girukubonye I, Barnhart DA, Cubaka VK, Niyigena PC, Nshunguyabahizi M, Mukamana B, Kateera F, Bitalabeho FA. Rwanda’s community health workers at the front line: a mixed-method study on perceived needs and challenges for community-based healthcare delivery during COVID-19 pandemic. BMJ Open. 2022;12(4):e055119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9058292</ArticleId><ArticleId IdType="pubmed">35487742</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakizimana D, Ntizimira C, Mbituyumuremyi A, Hakizimana E, Mahmoud H, Birindabagabo P, Musanabaganwa C, Gashumba D. The impact of Covid-19 on malaria services in three high endemic districts in Rwanda: a mixed-method study. Malar J. 2022;21(1):48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8845295</ArticleId><ArticleId IdType="pubmed">35164781</ArticleId></ArticleIdList></Reference><Reference><Citation>Encyclopaedia Britannica. Rwanda | Religion, population, language, &amp; capital | Britannica. 2023 [cited 2023 Aug 28]. https://www.britannica.com/place/Rwanda</Citation></Reference><Reference><Citation>Lwanga S, Sapirie S, Steinglass R, Stroh G, Wylie A. The department of immunization, vaccines and biologicals thanks the donors whose unspecified financial support has made the production of this publication possible and also gratefully acknowledges the assistance given to the authors by the. World Health Organ. 2005;129.</Citation></Reference><Reference><Citation>Worldometer. Rwanda population 2023 (Live). 2023 [cited 2023 Jul 23]. https://worldpopulationreview.com/countries/rwanda-population</Citation></Reference><Reference><Citation>Bujang MA, Omar ED, Baharum NA. A review on sample size determination for Cronbach’s alpha test: a simple guide for researchers. Malays J Med Sci. 2018;25(6):85–99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6422571</ArticleId><ArticleId IdType="pubmed">30914882</ArticleId></ArticleIdList></Reference><Reference><Citation>Al–Osail AM, Al–Sheikh MA, Al–Osail EM, Al–Ghamdi MA, Al–Hawas AM, Al–Bahussain AS, Al–Dajani AA. Is Cronbach’s alpha sufficient for assessing the reliability of the OSCE for an internal medicine course? BMC Res Notes. 2015;2(582):6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4612422</ArticleId><ArticleId IdType="pubmed">26482901</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4205511</ArticleId><ArticleId IdType="pubmed">28029643</ArticleId></ArticleIdList></Reference><Reference><Citation>Susan Jamieson. Likert scale | Social science surveys &amp; applications | Britannica. 2022 [cited 2023 Jun 27]. https://www.britannica.com/topic/Likert-Scale</Citation></Reference><Reference><Citation>Holzmann-Littig C, Braunisch MC, Kranke P, Popp M, Seeber C, Fichtner F, Littig B, Carbajo-Lozoya J, Allwang C, Frank T, Meerpohl JJ, Haller B, Schmaderer C. COVID-19 vaccination acceptance and hesitancy among healthcare workers in Germany. Vaccines. 2021;9(7):777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8310090</ArticleId><ArticleId IdType="pubmed">34358193</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7920465</ArticleId><ArticleId IdType="pubmed">33669441</ArticleId></ArticleIdList></Reference><Reference><Citation>Decouttere C, Banzimana S, Davidsen P, Van Riet C, Vandermeulen C, Mason E, Jalali MS, Vandaele N. Insights into vaccine hesitancy from systems thinking, Rwanda. Bull World Health Organ. 2021;99(11):783–D794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8542260</ArticleId><ArticleId IdType="pubmed">34737471</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakeel CS, Mujeeb AA, Mirza MS, Chaudhry B, Khan SJ. Global COVID-19 vaccine acceptance: a systematic review of associated social and behavioral factors. Vaccines. 2022;10(1):110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8779795</ArticleId><ArticleId IdType="pubmed">35062771</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzo RR, Ahmad A, Abid K, Khatiwada AP, Ahmed A, Kyaw TM, Abidin IBZ, Sridhar M, Sinnathamby S, Sarvasundram AP, Shrestha S. Factors influencing the acceptability of COVID-19 vaccination: a cross-sectional study from Malaysia. Vacunas. 2022;23:S33–40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8407950</ArticleId><ArticleId IdType="pubmed">34483788</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J, Liu AK, Zhang Z, Xu P, Guo Z, Liu X, Xu G, Wang A, Wang J, Wang X. Factors that impact acceptance of COVID-19 vaccination in different community-dwelling populations in China. Vaccines. 2022;10(1):91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8779453</ArticleId><ArticleId IdType="pubmed">35062753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus JV, Wyka K, White TM, Picchio CA, Gostin LO, Larson HJ, Rabin K, Ratzan SC, Kamarulzaman A, El-Mohandes A. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med. 2023;29(2):366–75.</Citation><ArticleIdList><ArticleId IdType="pubmed">36624316</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO, Achieving 70%. COVID-19 Immunization coverage by mid-2022. 2022 [cited 2023 Aug 29]. https://www.who.int/news/item/23-12-2021-achieving-70-covid-19-immunization-coverage-by-mid-2022</Citation></Reference><Reference><Citation>Johns Hopkins. COVID-19 vaccine acceptance falling globally and in the U.S., Survey Finds | Johns Hopkins | Bloomberg School of Public Health. Johns Hopkins Center for Communication Programs. [cited 2022 Sep 19]. https://publichealth.jhu.edu/2021/covid-19-vaccine-acceptance-falling-globally-and-in-the-us-survey-finds</Citation></Reference><Reference><Citation>Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021 [cited 2022 Sep 19];27(2):225–8. https://www.nature.com/articles/s41591-020-1124-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573523</ArticleId><ArticleId IdType="pubmed">33082575</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Elimat T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and attitudes toward COVID-19 vaccines: a cross-sectional study from Jordan. PLoS ONE. 2021;16(4):e0250555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064595</ArticleId><ArticleId IdType="pubmed">33891660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho FN, Ngah YE, Tassang AN, Fru CN, Kuku Elad PC, Jokwi PK, Folefac VN, Esa I, Fru PN. Face mask ownership/utilisation and COVID-19 vaccine hesitancy amongst patients recovering from COVID-19 in Cameroon: a cross-sectional study. PLoS ONE. 2023;18(1):e0280269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9858007</ArticleId><ArticleId IdType="pubmed">36662746</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabessa D, Bekele F. Willingness to receive the COVID-19 vaccine and associated factors among residents of Southwestern Ethiopia: A cross-sectional study. Patient Prefer Adherence. 2022 [cited 2023 May 23];16:1177–85. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078342/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9078342</ArticleId><ArticleId IdType="pubmed">35535255</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton-Jeangros C, Golay M, Sudre P. Compliance and resistance to child vaccination: a study among Swiss mothers. Rev Epidemiol Sante Publique. 2005;53(4):341–50.</Citation><ArticleIdList><ArticleId IdType="pubmed">16353509</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassell JA, Leach M, Poltorak MS, Mercer CH, Iversen A, Fairhead JR. Is the cultural context of MMR rejection a key to an effective public health discourse? Public Health. 2006;120(9):783–94.</Citation><ArticleIdList><ArticleId IdType="pubmed">16828492</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014 [cited 2022 Apr 14];32(19):2150–9. https://www.sciencedirect.com/science/article/pii/S0264410X14001443</Citation><ArticleIdList><ArticleId IdType="pubmed">24598724</ArticleId></ArticleIdList></Reference><Reference><Citation>Marti M, de Cola M, MacDonald NE, Dumolard L, Duclos P. Assessments of global drivers of vaccine hesitancy in 2014-looking beyond safety concerns. PLoS ONE. 2017;12(3):e0172310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5332020</ArticleId><ArticleId IdType="pubmed">28249006</ArticleId></ArticleIdList></Reference><Reference><Citation>Neff T, Kaiser J, Pasquetto I, Jemielniak D, Dimitrakopoulou D, Grayson S, Gyenes N, Ricaurte P, Ruiz-Soler J, Zhang A. Vaccine hesitancy in online spaces: a scoping review of the research literature, 2000–2020. Harv Kennedy Sch Misinformation Rev. 2021;2.</Citation></Reference><Reference><Citation>Fojnica A, Osmanovic A, Đuzic N, Fejzic A, Mekic E, Gromilic Z, Muhovic I, Kurtovic-Kozaric A. COVID-19 vaccine acceptance and rejection in an adult population in Bosnia and Herzegovina. PLoS ONE. 2022;17(2):e0264754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8884480</ArticleId><ArticleId IdType="pubmed">35226708</ArticleId></ArticleIdList></Reference><Reference><Citation>Robson J, Bao J, Wang A, McAlister H, Uwizihiwe JP, Sayinzoga F, Sibomana H, Koswin K, Wong J, Zlotkin S. Making sense of Rwanda’s remarkable vaccine coverage success. Int J Healthc. 2020;6(1):56.</Citation></Reference><Reference><Citation>Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573523</ArticleId><ArticleId IdType="pubmed">33082575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanyanda S, Markhof Y, Wollburg P, Zezza A. Acceptance of COVID-19 vaccines in Sub-Saharan Africa: evidence from six national phone surveys. Washington, DC: World Bank; 2021 [cited 2022 Sep 19]. https://openknowledge.worldbank.org/handle/10986/36039</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8678558</ArticleId><ArticleId IdType="pubmed">34911723</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinga JN, Sinda LK, Titanji VPK. Assessment of vaccine hesitancy to a COVID-19 vaccine in Cameroonian adults and its global implication. Vaccines. 2021;9(2):175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7922050</ArticleId><ArticleId IdType="pubmed">33669659</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubé E, Vivion M, MacDonald NE. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vaccines. 2015;14(1):99–117.</Citation><ArticleIdList><ArticleId IdType="pubmed">25373435</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayinzoga F, Umulisa MC, Sibomana H, Tenet V, Baussano I, Clifford GM. Human papillomavirus vaccine coverage in Rwanda: a population-level analysis by birth cohort. Vaccine. 2020;38(24):4001–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7221340</ArticleId><ArticleId IdType="pubmed">32336599</ArticleId></ArticleIdList></Reference><Reference><Citation>Favour E. 90 per cent children in Rwanda vaccinated against Polio. The New Times. 2022 [cited 2023 Sep 30]. https://www.newtimes.co.rw/article/2152/news/health/90-per-cent-children-in-rwanda-vaccinated-against-polio</Citation></Reference><Reference><Citation>Wibabara Y, Banura C, Kalyango J, Karamagi C, Kityamuwesi A, Amia WC, Ocama P. Hepatitis B vaccination status and associated factors among undergraduate students of Makerere University College of Health Sciences. PLoS ONE. 2019;14(4):e0214732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450609</ArticleId><ArticleId IdType="pubmed">30951543</ArticleId></ArticleIdList></Reference><Reference><Citation>LaMori J, Feng X, Pericone CD, Mesa-Frias M, Sogbetun O, Kulczycki A. Hepatitis vaccination adherence and completion rates and factors associated with low compliance: a claims-based analysis of U.S. adults. PLoS ONE. 2022;17(2):e0264062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8853527</ArticleId><ArticleId IdType="pubmed">35176102</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Agency of Canada. Vaccination coverage in Canadian children: results from the 2019 childhood national immunization coverage survey (cNICS). 2022 [cited 2023 Sep 30]. https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/2019-childhood-national-immunization-coverage-survey-results.html</Citation></Reference><Reference><Citation>Dubé E, Gagnon D, Nickels E, Jeram S, Schuster M. Mapping vaccine hesitancy–country-specific characteristics of a global phenomenon. Vaccine. 2014;32(49):6649–54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5355208</ArticleId><ArticleId IdType="pubmed">25280436</ArticleId></ArticleIdList></Reference><Reference><Citation>Taddio A. Setting the stage for improved practices during vaccine injections: a knowledge synthesis of interventions for the management of pain and fear. Clin J Pain. 2015;31(10 Suppl):S1–2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4900409</ArticleId><ArticleId IdType="pubmed">26163859</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">25896383</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein S, MacDonald NE, Guirguis S, SAGE Working Group on Vaccine Hesitancy. Health communication and vaccine hesitancy. Vaccine. 2015;33(34):4212–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">25896382</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Vaccine Action Plan. 2020 [cited 2023 Aug 24]. https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/global-vaccine-action-plan</Citation></Reference><Reference><Citation>Gust DA, Darling N, Kennedy A, Schwartz B. Parents with doubts about vaccines: which vaccines and reasons why. Pediatrics. 2008;122(4):718–25.</Citation><ArticleIdList><ArticleId IdType="pubmed">18829793</ArticleId></ArticleIdList></Reference><Reference><Citation>Opel DJ, Heritage J, Taylor JA, Mangione-Smith R, Salas HS, Devere V, Zhou C, Robinson JD. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132(6):1037–46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3838535</ArticleId><ArticleId IdType="pubmed">24190677</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>